Gut Microbiota, Oxidative Stress, and Inflammation: Pathophysiological Crosstalk in MASLD, MASH, and Hepatocellular Carcinoma
Davide Nilo1,*, Giovanni di Lorenzo1, Marco La Montagna1, Riccardo Nevola2, Aldo Marrone1, Ferdinando Carlo Sasso1, Alfredo Caturano3
BIOCELL, Vol.50, No.10, 2026, DOI:10.32604/biocell.2026.081324
- 22 September 2026
(This article belongs to the Special Issue: Cellular and Molecular Mechanisms of Gut Microbiota, Oxidative Stress, and Inflammation in Health and Disease)
Abstract Metabolically–dysfunction–associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and is increasingly recognized as a systemic disorder at the intersection of metabolic dysregulation, inflammation, and carcinogenesis. Progression from simple steatosis to metabolic dysfunction–associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC) reflects the interplay between metabolic overload, oxidative stress, immune activation, and gut microbiota dysbiosis. In this review, we propose the Redox–Microbiota–Inflammatory Axis as an integrative framework linking metabolic stress to fibrogenesis and hepatocarcinogenesis. Nutrient excess and insulin resistance promote mitochondrial dysfunction and reactive oxygen species (ROS) generation, which activate redox-sensitive inflammatory More >